DK2513135T3 - Fremgangsmåde til oprensning af polypeptider - Google Patents

Fremgangsmåde til oprensning af polypeptider Download PDF

Info

Publication number
DK2513135T3
DK2513135T3 DK10798291.0T DK10798291T DK2513135T3 DK 2513135 T3 DK2513135 T3 DK 2513135T3 DK 10798291 T DK10798291 T DK 10798291T DK 2513135 T3 DK2513135 T3 DK 2513135T3
Authority
DK
Denmark
Prior art keywords
polypeptides
purification
Prior art date
Application number
DK10798291.0T
Other languages
English (en)
Inventor
Mark Napoli
Paul Smrdelj
Anthony Stowers
Adam Charlton
Magnus Schröder
Ian Walker
Vicky Pirzas
Original Assignee
Csl Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42229094&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2513135(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Csl Ltd filed Critical Csl Ltd
Application granted granted Critical
Publication of DK2513135T3 publication Critical patent/DK2513135T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6437—Coagulation factor VIIa (3.4.21.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/644—Coagulation factor IXa (3.4.21.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21022—Coagulation factor IXa (3.4.21.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21021—Coagulation factor VIIa (3.4.21.21)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
DK10798291.0T 2009-12-18 2010-12-15 Fremgangsmåde til oprensning af polypeptider DK2513135T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09015707 2009-12-18
PCT/EP2010/069713 WO2011073235A1 (en) 2009-12-18 2010-12-15 Method of purifying polypeptides

Publications (1)

Publication Number Publication Date
DK2513135T3 true DK2513135T3 (da) 2020-05-18

Family

ID=42229094

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10798291.0T DK2513135T3 (da) 2009-12-18 2010-12-15 Fremgangsmåde til oprensning af polypeptider

Country Status (12)

Country Link
US (3) US20140080200A1 (da)
EP (3) EP4328305A2 (da)
JP (1) JP5984676B2 (da)
KR (1) KR20120108989A (da)
CN (2) CN102666568B (da)
AU (1) AU2010332959B2 (da)
CA (1) CA2783207A1 (da)
DK (1) DK2513135T3 (da)
ES (2) ES2968448T3 (da)
PL (1) PL3715356T3 (da)
SG (2) SG181496A1 (da)
WO (1) WO2011073235A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG181496A1 (en) 2009-12-18 2012-07-30 Csl Ltd Method of purifying polypeptides
NZ603289A (en) * 2010-04-29 2014-07-25 Baxter Int Purification method for divalent cation binding proteins on anion exchange resin
EP2702077A2 (en) 2011-04-27 2014-03-05 AbbVie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
JP6117219B2 (ja) 2011-10-14 2017-04-19 バクスアルタ ゲーエムベーハー 陰イオン交換クロマトグラフィによるタンパク質の精製方法
LT2748179T (lt) 2011-10-14 2022-04-11 Takeda Pharmaceutical Company Limited Baltymų gryninimas anijonų mainų chromatografija
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9334319B2 (en) 2012-04-20 2016-05-10 Abbvie Inc. Low acidic species compositions
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
US9505833B2 (en) 2012-04-20 2016-11-29 Abbvie Inc. Human antibodies that bind human TNF-alpha and methods of preparing the same
WO2013176754A1 (en) 2012-05-24 2013-11-28 Abbvie Inc. Novel purification of antibodies using hydrophobic interaction chromatography
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
US9206390B2 (en) 2012-09-02 2015-12-08 Abbvie, Inc. Methods to control protein heterogeneity
US10023608B1 (en) 2013-03-13 2018-07-17 Amgen Inc. Protein purification methods to remove impurities
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
WO2014159579A1 (en) 2013-03-14 2014-10-02 Abbvie Inc. MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
WO2014140289A1 (en) 2013-03-15 2014-09-18 Baxter International Inc. Purification method for vitamin k dependent proteins by anion exchange chromatography
EP3052640A2 (en) 2013-10-04 2016-08-10 AbbVie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
WO2017127567A1 (en) * 2016-01-19 2017-07-27 Genebiologics, Llc Production of arginine-rich proteins and use as a fertilizer and germination enhancer
CA3094644A1 (en) * 2018-03-21 2019-09-26 Baxalta Incorporated Separation of vwf and vwf propeptide by chromatographic methods
CN114787622A (zh) 2019-12-05 2022-07-22 沃特世科技公司 用于提高回收率并将***损失减到最小的聚膦酸

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US499437A (en) 1893-06-13 Ditching-scoop
DE3380848D1 (en) 1982-08-04 1989-12-21 Nat Res Dev Molecular cloning of the gene for human anti-haemophilic factor ix
US4879231A (en) 1984-10-30 1989-11-07 Phillips Petroleum Company Transformation of yeasts of the genus pichia
HU201775B (en) 1984-12-27 1990-12-28 Suntory Ltd Process for purifying interferon
GR860984B (en) 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
US4994371A (en) 1987-08-28 1991-02-19 Davie Earl W DNA preparation of Christmas factor and use of DNA sequences
US5061815A (en) * 1988-07-06 1991-10-29 Zinpro Corporation Metal lysine complexes and method for producing metal lysine complexes
EP0402226A1 (en) 1989-06-06 1990-12-12 Institut National De La Recherche Agronomique Transformation vectors for yeast yarrowia
US5641887A (en) * 1994-04-01 1997-06-24 University Of Pittsburgh Extraction of metals in carbon dioxide and chelating agents therefor
EP0829537A4 (en) * 1995-05-09 2000-05-03 Fujikawa Yoshio PEARL PROTEIN (NACREIN) AND PROCESS FOR PRODUCING THE SAME
US6268487B1 (en) * 1996-05-13 2001-07-31 Genzyme Transgenics Corporation Purification of biologically active peptides from milk
NZ335207A (en) 1996-11-15 2000-09-29 Genentech Inc Process to isolate recombinant human neurotrophin using hydrophobic chromatography resin
US20030036629A1 (en) 1997-12-12 2003-02-20 Barry Foster Novel tgf-beta protein purification methods
WO2000055203A1 (en) * 1999-03-15 2000-09-21 Novo Nordisk A/S Ion exchange chromatographic separation of glp-1 and related peptides
US7544500B2 (en) * 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
SE9904237D0 (sv) * 1999-11-22 1999-11-22 Ana Mar Diagnostics Ab New compound
SE0001128D0 (sv) 2000-03-30 2000-03-30 Amersham Pharm Biotech Ab A method of producing IgG
ATE482716T1 (de) 2001-11-13 2010-10-15 Genentech Inc Zusammensetzungen basierend auf apo2-ligand/ trail und ihre verwendung
US7741285B2 (en) 2001-11-13 2010-06-22 Genentech, Inc. APO-2 ligand/trail formulations
DK1501369T3 (da) 2002-04-26 2015-09-28 Genentech Inc Ikke-affinitetsoprensning af proteiner
AU2003242507A1 (en) * 2002-07-12 2004-02-02 Novo Nordisk A/S A tissue factor binding immunoconjugate comprising factor viia
US20040048315A1 (en) * 2002-08-28 2004-03-11 Pharmacia Corporation Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof
PT1428878E (pt) * 2002-12-13 2008-11-18 Bioceuticals Arzneimittel Ag Processo para a produção e purificação de eritropoietina
CN101031644A (zh) * 2004-09-29 2007-09-05 诺和诺德医疗保健公司 通过分级洗脱从阴离子交换材料中纯化批量凝血因子ⅶ多肽
JP2008525381A (ja) 2004-12-23 2008-07-17 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 関心のあるビタミンｋ依存性タンパク質を含んでなる組成物中におけるタンパク質混入物の量の減少
WO2006110277A1 (en) 2005-04-11 2006-10-19 Medarex, Inc. Protein purification using hcic amd ion exchange chromatography
CA2621236A1 (en) * 2005-08-31 2007-03-08 Centocor, Inc. Host cell lines for production of antibody constant region with enhanced effector function
WO2007026020A1 (en) * 2005-09-01 2007-03-08 Novo Nordisk Health Care Ag Purification of coagulation factor vii polypeptides
EP1966232A1 (en) 2005-12-23 2008-09-10 Novo Nordisk A/S Purification of proteins using preparative reverse phase chromatography (rpc)
CN101437839A (zh) 2006-03-20 2009-05-20 米德列斯公司 蛋白质纯化
NZ611859A (en) 2006-04-05 2014-12-24 Abbvie Biotechnology Ltd Antibody purification
JP5800458B2 (ja) 2006-06-14 2015-10-28 ツェー・エス・エル・ベーリング・ゲー・エム・ベー・ハー 血液凝固因子を有するタンパク質分解によって切断可能な融合タンパク質
JP5374840B2 (ja) * 2006-07-20 2013-12-25 Ｊｎｃ株式会社 カルシウム結合発光蛋白質、それをコードする遺伝子およびその用途
MX2009002576A (es) 2006-09-08 2009-03-20 Wyeth Corp Lavado de arginina en purificacion de proteina utilizando cromatografia de afinidad.
US8362217B2 (en) 2006-12-21 2013-01-29 Emd Millipore Corporation Purification of proteins
EP2120915B1 (en) 2007-01-22 2011-09-28 Genentech, Inc. Polyelectrolyte precipitation and purification of antibodies
EP2125866B1 (en) * 2007-02-28 2013-05-22 Baxter International Inc. Method for the purification of recombinant blood coagulation factor ix enriched in sulfated and/or phosphorylated molecules
US20100273983A1 (en) 2007-04-05 2010-10-28 The University Of Queensland Method of purifying peptides by selective precipitation
TWI472339B (zh) 2008-01-30 2015-02-11 Genentech Inc 包含結合至ｈｅｒ２結構域ii之抗體及其酸性變異體的組合物
WO2009149067A1 (en) 2008-06-03 2009-12-10 Patrys Limited Process for purification of antibodies
MX2011005474A (es) * 2008-12-02 2011-06-16 Novo Nordisk Healthcare Ag Purificacion de polipeptido.
WO2011018515A1 (en) * 2009-08-14 2011-02-17 Novo Nordisk Health Care Ag Method of purifying pegylated proteins
SG181496A1 (en) 2009-12-18 2012-07-30 Csl Ltd Method of purifying polypeptides

Also Published As

Publication number Publication date
CA2783207A1 (en) 2011-06-23
JP2013514310A (ja) 2013-04-25
EP3715356C0 (en) 2023-10-11
CN104193798A (zh) 2014-12-10
EP2513135B1 (en) 2020-04-22
JP5984676B2 (ja) 2016-09-06
KR20120108989A (ko) 2012-10-05
EP3715356B1 (en) 2023-10-11
US20160185816A1 (en) 2016-06-30
AU2010332959A1 (en) 2012-07-05
ES2796829T3 (es) 2020-11-30
AU2010332959B2 (en) 2015-08-06
ES2968448T3 (es) 2024-05-09
US20190330267A1 (en) 2019-10-31
CN102666568B (zh) 2015-12-09
CN102666568A (zh) 2012-09-12
SG10201407983VA (en) 2015-01-29
WO2011073235A1 (en) 2011-06-23
PL3715356T3 (pl) 2024-03-11
EP2513135A1 (en) 2012-10-24
EP3715356A1 (en) 2020-09-30
SG181496A1 (en) 2012-07-30
EP4328305A2 (en) 2024-02-28
US20140080200A1 (en) 2014-03-20

Similar Documents

Publication Publication Date Title
DK2513135T3 (da) Fremgangsmåde til oprensning af polypeptider
DK3354657T3 (da) Fremgangsmåde til fremstilling af planteafledte proteiner
DK2398817T4 (da) Fremgangsmåde til rensning af lipopeptider
DK2300497T3 (da) Fremgangsmåde til oprensning af koagulationsfaktor VIII
DK2488867T3 (da) Fremgangsmåder til affinitetsmodning af antistoffer
DK1974806T3 (da) Fremgangsmåde til rensning af vand
DK2526114T3 (da) Kromatografisk fremgangsmåde til oprensning af FC-indeholdende proteiner
DK2496562T3 (da) Fremgangsmåde til fremstilling af calcobutrol
DK2411490T3 (da) Fremgangsmåde til fremstilling af bioolie
DK2438019T3 (da) Fremgangsmåde til biologisk rensning af spildevand
DK2408561T3 (da) Fremgangsmåde til isolering af partikler
DK2260873T3 (da) Pcylering af proteiner
DK2598516T3 (da) Fremgangsmåde til proteinoprensning
DK3214083T3 (da) Fremgangsmåde til fremstilling af quinolonforbindelser
DK2467220T3 (da) Anordning til udvidelse af hullegemer
DK2417152T3 (da) Fremgangsmåde til isolering af linaclotid
DK2178900T3 (da) Oprensning af pegylerede polypeptider
DK2391225T3 (da) Fremgangsmåde til fremstilling af lactoferrin
DK3133157T3 (da) Fremgangsmåde til oprensning af vitamin k-afhængige proteiner
DK2554171T3 (da) Fremgangsmåde til behandling af sygdomme
DK2582776T3 (da) Fremgangsmåde til opdræt af ascidier
DK2516359T3 (da) Fremgangsmåde til fremstilling af ethylbenzen
DK2462108T3 (da) Fremgangsmåde til fremstilling af pyrazolcarboxylsyreamider
DK2926761T3 (da) Apparat til korrigering af tænder
DK2427482T3 (da) Method for purification of target polypeptides